Skip to main content
Sanofi logo

Sanofi — Investor Relations & Filings

Ticker · SAN ISIN · FR0000120578 LEI · 549300E9PC51EN656011 PA Manufacturing
Filings indexed 4,405 across all filing types
Latest filing 2025-12-22 Transaction in Own Shar…
Country FR France
Listing PA SAN

Sanofi is a global biopharmaceutical company dedicated to the discovery, development, manufacturing, and marketing of therapeutic solutions. The company's portfolio includes a wide range of medicines and vaccines designed to improve human health. Sanofi focuses on several key therapeutic areas, including immunology, oncology, rare diseases, neurology, and vaccines. Emphasizing a research-driven approach, the company increasingly utilizes artificial intelligence to innovate and accelerate the delivery of new treatments for patients worldwide. Sanofi is also a producer of active pharmaceutical ingredients.

Recent filings

Filing Released Lang Actions
Sanofi : Déclaration des transactions sur actions propres
Transaction in Own Shares Classification · 100% confidence The document is a formal disclosure titled 'Déclaration des transactions sur actions propres' (Declaration of transactions in own shares) for Sanofi. It provides a detailed, transaction-by-transaction breakdown of share repurchases conducted between December 15, 2025, and December 19, 2025, including volumes, prices, and market identifiers. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS).
2025-12-22 English
Sanofi: Disclosure of trading in own shares
Transaction in Own Shares Classification · 100% confidence The document is titled 'Disclosure of trading in own shares' and provides a detailed breakdown of share repurchases by Sanofi over a specific period (15 December 2025 to 19 December 2025). It includes tables showing daily volumes, weighted average prices, and individual transaction details, which is the standard format for reporting share buybacks under Market Abuse Regulation (MAR). This fits the definition of 'Transaction in Own Shares' (POS).
2025-12-22 English
6-K
Foreign Filer Report
2025-12-22 English
Communiqué de presse : Sanofi conclut un accord avec le gouvernement américain pour réduire le coût des médicaments et renforcer l’innovation
Regulatory Filings Classification · 95% confidence The document is a press release issued by Sanofi announcing a voluntary agreement with the U.S. government regarding drug pricing, innovation, and manufacturing investments. It does not fit into specific financial reporting categories like 10-K, IR, or ER, nor is it a simple report publication announcement (RPA) as it contains substantive details of the agreement itself. Given that it is a general corporate announcement regarding regulatory and strategic matters, it falls under the 'Regulatory Filings' (RNS) category as the appropriate fallback.
2025-12-19 French
Press Release: Sanofi reaches agreement with the US government to lower medicine costs while strengthening innovation
Regulatory Filings Classification · 95% confidence The document is a press release issued by Sanofi announcing a voluntary agreement with the US government regarding medicine pricing, manufacturing investments, and tariff exemptions. It does not constitute a formal financial report, audit, or proxy statement. As it is a general corporate announcement regarding business strategy and government relations that does not fit into more specific categories like M&A or dividend notices, it is classified as a Regulatory Filing (RNS).
2025-12-19 English
Communiqué de presse : Mise en ligne du document «Q4 2025 Aide mémoire »
Report Publication Announcement Classification · 100% confidence The document is a press release announcing the publication of a supplementary document ('Q4 2025 Aide mémoire') on the company's website. It explicitly states that the purpose of the release is to inform the financial community that this modeling aid is now available online. Following the 'Menu vs Meal' rule, since this is an announcement of a report rather than the report itself, it is classified as a Report Publication Announcement (RPA).
2025-12-17 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.